Abram Scientific

Abram Scientific's CoagCare Platform: A New Diagnostic Platform for Diagnosing and Characterizing Coagulation-Related DiseasesThe CoagCare platform developed by Abram Scientific is a new diagnostic platform used for diagnosing and characterizing coagulation-related diseases, providing rapid hemostasis information to improve clinical outcomes. The platform aims to utilize proprietary technology to quickly (<10 minutes) and accurately measure blood viscoelasticity and density. In contrast, current global coagulation diagnostic platforms, such as thromboelastography and thromboelastometry, require 30-60 minutes to complete measurements. CoagCare is expected to be the first of its kind, capable of rapidly analyzing the entire coagulation cascade from clot formation to dissolution, quantifying the impact of specific coagulation factor deficiencies or inhibitors, thereby enabling personalized diagnosis and management of coagulation-related diseases.